YAMASHITA HEALTH CARE HOLDINGS, INC. (9265) AI Stock Analysis

• Market Cap: ¥7.89B
• Dividend Yield: 2%
• Average Volume (3M): 1.08K
• Price to Earnings (P/E): 12.4
• Beta (1Y): 0.58
• Revenue Growth: 4.76%
• EPS Growth: 9.55%
• Country: JP
• Employees: 606
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Distribution
• EPS (TTM): 63.08
• Shares Outstanding: 2,553,000
• 10 Day Avg. Volume: 620
• 30 Day Avg. Volume: 1,076
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 76 Outperform
• Price Target: ―

YAMASHITA HEALTH CARE HOLDINGS, INC. is fundamentally strong with a solid balance sheet and positive revenue growth. While cash flow generation needs improvement, the stock's undervaluation and upward price momentum contribute positively to its appeal.

YAMASHITA HEALTH CARE HOLDINGS, INC. Business Overview & Revenue Model

Company Description

YAMASHITA HEALTH CARE HOLDINGS, INC. (9265) operates in the healthcare sector, focusing on the distribution and sale of medical supplies and equipment. The company provides a range of products including medical devices, pharmaceuticals, and health-related consumables to hospitals, clinics, and other healthcare providers, ensuring efficient and reliable access to essential healthcare materials.

How the Company Makes Money

YAMASHITA HEALTH CARE HOLDINGS, INC. generates revenue primarily through the sale of medical supplies and equipment. The company maintains partnerships with manufacturers to distribute a wide array of products to healthcare facilities. Revenue streams include direct sales to hospitals and clinics, as well as long-term supply contracts with healthcare institutions. Additionally, the company may engage in value-added services such as equipment maintenance and consulting, contributing to diversified income sources.

YAMASHITA HEALTH CARE HOLDINGS, INC. Financial Statement Overview

Summary

YAMASHITA HEALTH CARE HOLDINGS, INC. shows solid revenue growth and a strong balance sheet with zero debt, enhancing financial stability. However, challenges in cash flow generation and modest net profitability indicate areas for improvement.

Income Statement

YAMASHITA HEALTH CARE HOLDINGS, INC. has demonstrated solid revenue growth over the past year, with a revenue increase of 5.76%. The gross profit margin of 13.49% and net profit margin of 0.94% indicate healthy operational efficiency, although there is room for improvement in net profitability. The EBIT margin of 1.57% and EBITDA margin of 1.76% suggest moderate operational performance, and the company has shown resilience in maintaining profitability despite industry challenges.

Balance Sheet

The company maintains a strong balance sheet with a debt-free position and a solid equity base. The equity ratio of 32.17% indicates a well-capitalized structure, while a return on equity (ROE) of 6.79% reflects modest profitability relative to shareholder investment. The absence of debt enhances financial stability and reduces risk exposure.

Cash Flow

There has been a significant decline in operating cash flow, dropping by 59.44% from the previous year, which is a concern for cash generation. However, the free cash flow to net income ratio of 1.38 demonstrates the company's ability to convert profits into cash effectively. Despite a drop in free cash flow growth, the company maintains positive free cash flow, supporting future growth investments.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	63.73B	64.49B	61.55B	58.20B	55.15B	70.13B
Gross Profit	8.72B	8.57B	8.50B	8.05B	7.72B	7.51B
EBITDA	1.13B	1.17B	1.09B	840.00M	1.25B	1.25B
Net Income	598.00M	616.00M	580.00M	219.00M	696.00M	678.49M
Balance Sheet
Total Assets	25.62B	27.55B	26.56B	24.57B	24.09B	24.32B
Cash, Cash Equivalents and Short-Term Investments	4.11B	5.70B	5.30B	5.83B	3.98B	3.65B
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00
Total Liabilities	16.90B	18.56B	18.00B	16.64B	16.08B	16.74B
Stockholders Equity	8.71B	8.98B	8.54B	7.91B	7.98B	7.58B
Cash Flow
Free Cash Flow	0.00	338.00M	801.00M	2.08B	462.71M	765.29M
Operating Cash Flow	0.00	617.00M	878.00M	2.17B	581.27M	911.53M
Investing Cash Flow	0.00	19.00M	-1.07B	-107.00M	-27.66M	-134.14M
Financing Cash Flow	0.00	-240.00M	-335.00M	-209.00M	-230.00M	-137.81M

YAMASHITA HEALTH CARE HOLDINGS, INC. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 3090.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9265, the sentiment is Positive. The current price of 3090 is below the 20-day moving average (MA) of 3096.75, above the 50-day MA of 3002.40, and above the 200-day MA of 2630.79, indicating a neutral trend. The MACD of 2.91 indicates Positive momentum. The RSI at 48.79 is Neutral, neither overbought nor oversold. The STOCH value of 66.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:9265.

YAMASHITA HEALTH CARE HOLDINGS, INC. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
9265	76 Outperform	¥7.89B	12.39		2.00%	4.76%	9.55%
7649	75 Outperform	713.94B	16.93	10.25%	0.91%	20.18%	82.36%
3321	74 Outperform	11.21B	6.74	10.82%	4.26%	152.38%	38.72%
3359	69 Neutral	6.07B	14.48	8.20%	1.43%	36.83%	1.34%
7451	68 Neutral	274.72B	11.49	10.63%	2.93%	1.49%	6.34%
3341	63 Neutral	113.63B	52.61	2.35%	0.64%	6.77%	28.06%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%